Clinical trial

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Biospecimen Collection Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Computed Tomography Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Magnetic Resonance Imaging Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Medical Chart Review Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Paracentesis Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Positron Emission Tomography Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

National Cancer Institute "Cancer Moonshot Biobank"

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2020-11-11

PhaseN/A

Conditions

Acute Myeloid Leukemiaverified · MONDO: acute myeloid leukemia

Anatomic Stage III Breast Cancer AJCC v8unresolved

Anatomic Stage IV Breast Cancer AJCC v8unresolved

Clinical Stage IV Esophageal Adenocarcinoma AJCC v8unresolved

Clinical Stage IV Gastric Cancer AJCC v8unresolved

Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8unresolved

Esophageal Carcinomaverified · MONDO: carcinoma of esophagus

Fallopian Tube Carcinomaverified · MONDO: fallopian tube carcinoma

Gastric Carcinomaverified · MONDO: gastric carcinoma

Hormone Receptor-Positive Breast Carcinomaunresolved

Invasive Breast Carcinomaverified · MONDO: invasive breast carcinoma

Lung Non-Small Cell Carcinomaunresolved

Lung Small Cell Carcinomaverified · MONDO: small cell lung carcinoma

Malignant Solid Neoplasmunresolved

Melanomaverified · MONDO: melanoma

Metastatic Prostate Carcinomaverified · MONDO: metastatic prostate carcinoma

Multiple Myelomaunresolved

Ovarian Carcinomaverified · MONDO: ovarian carcinoma

Ovarian High Grade Serous Adenocarcinomaunresolved

Primary Peritoneal Carcinomaverified · MONDO: primary peritoneal carcinoma

Stage III Fallopian Tube Cancer AJCC v8unresolved

Stage III Lung Cancer AJCC v8unresolved

Stage III Ovarian Cancer AJCC v8unresolved

Stage IV Colorectal Cancer AJCC v8unresolved

Stage IV Fallopian Tube Cancer AJCC v8unresolved

Stage IV Lung Cancer AJCC v8unresolved

Stage IV Ovarian Cancer AJCC v8unresolved

Stage IVB Prostate Cancer AJCC v8unresolved

Triple-Negative Breast Carcinomaverified · MONDO: triple-negative breast carcinoma

Interventions

Biospecimen CollectionPROCEDURE

Computed TomographyPROCEDURE

Magnetic Resonance ImagingPROCEDURE

Medical Chart ReviewOTHER

ParacentesisPROCEDURE

Positron Emission TomographyPROCEDURE

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

Las VegasNevada, United States7 St LouisMissouri, United States4 The BronxNew York, United States4 San JuanPuerto Rico3 Des MoinesIowa, United States3 ChicagoIllinois, United States2 RichmondVirginia, United States2 New OrleansLouisiana, United States2 ColumbiaSouth Carolina, United States2 SpringfieldMissouri, United States2 GreenvilleNorth Carolina, United States2 DecaturIllinois, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04314401 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.